HHealthcare Read More Meet Ottava, J&J’s surgical robot leading the healthcare giant into a lucrative new marketSeptember 11, 2026 Johnson & Johnson is diving head-first into the deep end of the competitive robotic surgery market. The payoff…
HHealthcare Read More Johnson & Johnson Stock Jumps 3% as Healthcare Rotation Lifts SharesAugust 19, 2026 This article first appeared on GuruFocus. Johnson & Johnson (NYSE:JNJ), the healthcare heavyweight behind blockbuster medicines and medical…
AArtificial intelligence Read More Inflation moderated as Intel and Nvidia fueled the AI trade in last week’s marketAugust 15, 2026 No surprises on inflation and new financing developments in the artificial intelligence trade drove the record-breaking action on…
HHealthcare Read More We’re lifting our price target on Cardinal Health after issuing rosy profit guidanceAugust 12, 2026 Cardinal Health on Tuesday showed why the healthcare distributor belongs in our portfolio, delivering robust full-year earnings guidance…
HHealthcare Read More Can Johnson & Johnson (JNJ) Challenge Intuitive Surgical (ISRG) After Ottava’s FDA Approval?August 11, 2026 Johnson & Johnson (NYSE:JNJ) has officially entered the U.S. soft-tissue robotic surgery market after receiving FDA De Novo…
AArtificial intelligence Read More AI stocks rebound, and why J&J’s earnings guidance cut is not cause for concernJuly 30, 2026 Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just…
PPersonal finance Read More How a 44-Year-Old Could Build a $9,000 Monthly Paycheck by 60 Without Maxing a 401(k)July 29, 2026 Quick Read Generating $108,000 annually from dividends requires roughly $2.7M at a 4% yield, $1.8M at 6%, or…
AArtificial intelligence Read More Jim Cramer says Wall Street is fleeing the AI trade and buying these stocks insteadJuly 29, 2026 CNBC’s Jim Cramer said Tuesday that Wall Street is taking profits in this year’s biggest AI infrastructure winners…
HHealthcare Read More Johnson & Johnson (JNJ) Raised Its Outlook. Is It the Better Healthcare Stock to Own After Earnings?July 28, 2026 Johnson & Johnson (NYSE:JNJ) delivered strong fiscal Q2 2026 results, with sales for the quarter growing nearly 7%…
HHealthcare Read More J&J Finally Has a Rival to da Vinci. 1 Number in Intuitive Surgical’s Last Quarter Says It Won’t Be Enough to Move the Needle for JNJ Stock.July 25, 2026 Intuitive Surgical Inc location sign-by Sundry Photography via iStock Intuitive Surgical (ISRG) shares closed lower on July 22…
HHealthcare Read More Johnson & Johnson vs Abbott Laboratories: Two Healthcare Giants on Opposite TrajectoriesJuly 23, 2026 Quick Read JNJ’s 64-year dividend streak and oncology momentum make it the steadier buy, while ABT’s 18x forward…
HHealthcare Read More Market for psychedelic drugs to treat mental health gets a buy signalJuly 19, 2026 Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement…